The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Open accessAbstract
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus that since its emergence in 2012 has caused outbreaks in human populations with case-fatality rates of ∼36%. As in other coronaviruses, the spike (S) glycoprotein of MERS-CoV mediates receptor recognition and membrane fusion and is the primary target of the humoral immune response during infection. Here we use structure-based design to develop a generalizable strategy for retaining coronavirus S proteins in the antigenically optimal prefusion conformation and demonstrate that our engineered immunogen is able to elicit high neutralizing antibody titers against MERS-CoV. We also determined high-resolution structures of the trimeric MERS-CoV S ectodomain in complex with G4, a stem-directed neutralizing antibody. The structures reveal that G4 recognizes a glycosylated loop that is variable among coronaviruses and they define four conformational states of the trimer wherein each receptor-binding domain is either tightly packed at the membrane-distal apex or rotated into a receptor-accessible conformation. Our studies suggest a potential mechanism for fusion initiation through sequential receptor-binding events and provide a foundation for the structure-based design of coronavirus vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both vaccines encode the same full-length, pre-fusion stabilized severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein13,14 and are encapsulated in lipid nanoparticles (LNPs) with identical composition.”
From Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine (2022) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Stabilizing coronavirus spike proteins by substituting two prolines at the top of heptad repeat 1 prevents structural rearrangements of the fusion (S2) subunit.”
From An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, S-2P conformational stability translates into greater immunogenicity,27-29 based on preservation of neutralization-sensitive epitopes at the apex of the prefusion molecule, as shown for respiratory syncytial virus F glycoprotein,30 and improved protein expression,27 which is particularly advantageous for gene-based antigen delivery.”
From An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) · cites this paper as [27]
In the citing paper
“Immune responses are improved by introducing two consecutive proline residues (2P), which are known to retain the full-length S protein in the prefusion conformation.64,65”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 46,047
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
RELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
How good are my data and what is the resolution?
Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,743
Comparative Protein Structure Modeling Using MODELLER
Webb, B., & Šali, A. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.3 · Cited by 4,404
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw408 · Cited by 3,163
Cited by
Sorted by citations
Items 601–700 of 1,000
Volkan, E. (2021) · Molecular Biotechnology · doi:10.1007/s12033-021-00353-4 · Cited by 12
Contributions of single-particle cryoelectron microscopy toward fighting COVID-19
Rapp, M., Shapiro, L. S., & Frank, J. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.10.005 · Cited by 12
Zhong, C., Xia, H., Adam, A., Wang, B., Hajnik, R. L., Liang, Y., Rafael, G. H., Zou, J., Wang, X., Sun, J., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00405-5 · Cited by 13
Shahrajabian, M. H. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220321102216 · Cited by 13
Park, H.-S., Matsuoka, Y., Luongo, C., Yang, L., Santos, C. P., Liu, X., Ahlers, L. R. H., Moore, I. N., Afroz, S., Johnson, R. F., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00493-x · Cited by 12
Lorenzo, M. M., Marín-López, A., Chiem, K., Jiménez-Cabello, L., Ullah, I., Utrilla-Trigo, S., Calvo-Pinilla, E., Lorenzo, G., Moreno, S., Ye, C., et al. (2023) · Vaccines · doi:10.3390/vaccines11051006 · Cited by 12
Comparison of DNA vaccines with AddaS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
Neeli, P. K., Chai, D., Wang, X., Sobhani, N., Udeani, G., & Li, Y. (2023) · iScience · doi:10.1016/j.isci.2023.107120 · Cited by 13
Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development
Toth, E. A., Chagas, A. C., Pierce, B. G., & Fuerst, T. R. (2021) · Viruses · doi:10.3390/v13061027 · Cited by 12
The Pathophysiology of Virulence of the COVID-19 VirusPreprint
Soto, J. D., Hakim, S. T., & Boyd, F. (2020) · Preprints.org · doi:10.20944/preprints202004.0077.v1 · Cited by 12
Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
Weng, Y., & Huang, Y. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.02.005 · Cited by 12
ACE2 from Pipistrellus abramus bats is a receptor for HKU5 coronavirusesPreprint
Catanzaro, N., Wu, Z., Fan, C., Schäfer, A., Yount, B. L., Björkman, P. J., Baric, R. S., & Letko, M. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.13.584892 · Cited by 12
Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen
McCool, R. S., Acreman, C. M., Powell, A. E., Picucci, S. I., Stieh, D. J., Chou, C., Huynh, J., Caruso, H., Park, S., O’Rear, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67969-x · Cited by 11
Self-citationAnsori, A. N. M., Kharisma, V. D., Antonius, Y., Tacharina, M. R., & Rantam, F. A. (2020) · Jurnal Teknologi Laboratorium · doi:10.29238/teknolabjournal.v9i1.221 · Cited by 11
Cryo-electron microscopy in the study of virus entry and infection
Dutta, M., & Acharya, P. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1429180 · Cited by 12
SARS-CoV-2 spike-induced syncytia are senescent and contribute to exacerbated heart failure
Li, H., Wan, L., Liu, M., Ma, E., Huang, L., Yang, Y., Li, Q., Fang, Y., Li, J., Han, B., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012291 · Cited by 11
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation
Stein, S. C., Hansen, G., Ssebyatika, G. L., Stroh, L. J., Ochulor, O., Herold, E., Schwarzloh, B., Mutschall, D., Zischke, J., Cordes, A. K., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01223-24 · Cited by 12
Langowski, M. D., Francica, J. R., Roederer, A. L., Hurlburt, N. K., Rodarte, J. V., Pereira, L. D. S., Flynn, B. J., Bonilla, B. G., Dillon, M., Kiyuka, P. K., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01140-x · Cited by 12
Potential of X-ray free-electron lasers for challenging targets in structure-based drug discovery
Kovacs, G. N. (2021) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2021.08.002 · Cited by 11
Dubé, C., Paris‐Robidas, S., Primakova, I., Destexhe, É., Ward, B. J., Landry, N., & Trépanier, S. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.11.006 · Cited by 11
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
Cable, J., Fauci, A. S., Dowling, W. E., Günther, S., Bente, D. A., Yadav, P. D., Madoff, L. C., Wang, L., Arora, R. K., Kerkhove, M. D. V., et al. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14898 · Cited by 12
Self-citationAntigenic mapping reveals sites of vulnerability on α-HCoV spike protein
Xiang, J., Su, J., Lan, Q., Zhao, W., Zhou, Y., Xu, Y., Niu, J., Xia, S., Qi, Q., Sidhu, S. S., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04160-8 · Cited by 11
Durable immune responses after BNT162b2 vaccination in home-dwelling old adults
Hansen, L., Brokstad, K. A., Bansal, A., Zhou, F., Bredholt, G., Onyango, T. B., Sandnes, H. H., Elyanow, R., Madsen, A., Trieu, M.-C., et al. (2023) · Vaccine X · doi:10.1016/j.jvacx.2023.100262 · Cited by 12
Hollingsworth, S. A., Noland, C. L., Vroom, K., Saha, A., Sam, M., Gao, Q., Zhou, H., Grandy, D. U., Singh, S., Wen, Z., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40919-7 · Cited by 10
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
Romano, E., Pascolo, S., & Ott, P. A. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002932 · Cited by 11
Wang, Q., & Liu, Z. (2021) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2021.100003 · Cited by 11
Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease
Hussman, J. P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.637642 · Cited by 11
Characterization of a SARS-CoV-2 spike protein reference material
Stocks, B. B., Thibeault, M.-P., Schrag, J. D., & Melanson, J. E. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04000-y · Cited by 12
mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates
Waickman, A. T., Victor, K., Newell, K. L., Li, T., Friberg, H., Foulds, K. E., Roederer, M., Bolton, D. L., Currier, J. R., & Seder, R. A. (2022) · JCI Insight · doi:10.1172/jci.insight.160039 · Cited by 11
Mucker, E. M., Brocato, R. L., Principe, L. M., Kim, R. K., Zeng, X., Smith, J. M., Kwilas, S. A., Kim, S., Horton, H., Caproni, L. J., et al. (2022) · Vaccines · doi:10.3390/vaccines10071104 · Cited by 11
Hayashi, H., Sun, J., Yanagida, Y., Otera, T., Sasai, M., Chang, C. Y., Tai, J. A., Nishikawa, T., Yamashita, K., Sakaguchi, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24519-5 · Cited by 11
Muñoz-Alía, M. Á., Nace, R. A., Balakrishnan, B., Zhang, L., Packiriswamy, N., Singh, G., Warang, P., Mena, I., Narjari, R., Vandergaast, R., et al. (2024) · mBio · doi:10.1128/mbio.02928-23 · Cited by 12
Hauser, B. M., Sangesland, M., Lam, E. C., Denis, K. S., Feldman, J. E., Yousif, A. S., Caradonna, T. M., Kannegieter, T., Balazs, A. B., Lingwood, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.07.415216 · Cited by 11
Sentinel cells enable genetic detection of SARS-CoV-2 Spike proteinPreprint
Weinberg, Z. Y., Hilburger, C. E., Kim, M. J., Cao, L., Khalid, M. M., Elmes, S., Diwanji, D. C., Hernandez, E., Lopez, J., Schaefer, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.20.440678 · Cited by 12
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesPreprint
Corbett, K. S., Werner, A. P., Connell, S. O., Gagné, M., Lai, L., Moliva, J. I., Flynn, B. J., Choi, A., Koch, M. J., Foulds, K. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.21.445189 · Cited by 11
Self-citationEvolving spike-protein N -glycosylation in SARS-CoV-2 variantsPreprint
Baboo, S., Diedrich, J. K., Torres, J. L., Copps, J., Singh, B., Garrett, P. T., Ward, A. B., Paulson, J. C., & Yates, J. R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.08.539897 · Cited by 10
Self-citationKumar, R., Maji, S., Tiwari, S., Misra, J. P., Gupta, J., Kumar, N., Gupta, R., & Jha, N. K. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117349 · Cited by 11
Isolation and escape mapping of broadly neutralizing antibodies against emerging delta-coronaviruses
Rexhepaj, M., Asarnow, D. E., Perruzza, L., Park, Y., Guarino, B., Mccallum, M., Culap, K., Saliba, C., Leoni, G., Balmelli, A., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.10.001 · Cited by 10
Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses
Baric, T. J., & Reneer, Z. B. (2024) · Viruses · doi:10.3390/v17010001 · Cited by 10
New insights on possible vaccine development against SARS-CoV-2
Chaudhry, S. N., Hazafa, A., Mumtaz, M., Kalsoom, U., Abbas, S., Kainaat, A., Bilal, S., Zafar, N., Siddique, A., & Zafar, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118421 · Cited by 10
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2
Gupta, S. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200922112300 · Cited by 10
Banerjee, R., Basak, K., Ghosh, A., Rajachandran, V., Sureka, K., Ganguly, D., & Chattopadhyay, S. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104874 · Cited by 10
Baron, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., Beguin, Y. P., Marchant, A., & Humblet‐Baron, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.827242 · Cited by 12
Lim, H. T., Kok, B. H., Lim, C. P., Majeed, A. B. A., Leow, C. Y., & Leow, C. Y. (2022) · Biomedical Engineering Advances · doi:10.1016/j.bea.2022.100054 · Cited by 10
Ching, W. Y., Adhikari, P., Jawad, B., & Podgornik, R. (2023) · Biomedicines · doi:10.3390/biomedicines11020517 · Cited by 9
Liu, X., Song, H., Jiang, J., Gao, X., Yi, Y., Shang, Y., Li, J., Li, D., Zeng, Z., Li, Y., et al. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.03.026 · Cited by 12
Spike substitution T813S increases Sarbecovirus fusogenicity by enhancing the usage of TMPRSS2
Ma, Y., Li, P., Hu, Y., Qiu, T., Wang, L., Lu, H., Lv, K., Xu, M., Zhuang, J., Liu, X., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011123 · Cited by 10
Self-citationWarner, B. M., Yates, J. G. E., Vendramelli, R., Truong, T., Meilleur, C. E., Chan, L., Leacy, A., Pham, P. H., Pei, Y., Susta, L., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00870-8 · Cited by 12
Structure and Immune Recognition of the Porcine Epidemic Diarrhea Virus Spike Protein
Kirchdoerfer, R. N., Bhandari, M., Martini, O., Sewall, L. M., Bangaru, S., Yoon, K.-J., & Ward, A. B. (2020) · Microscopy and Microanalysis · doi:10.1017/s1431927620021923 · Cited by 10
Self-citationKaur, K. K., Allahbadia, G., & Singh, M. (2020) · Iberoamerican Journal of Medicine · doi:10.53986/ibjm.2020.0019 · Cited by 11
Hu, L., Xu, Y., Wu, L., Feng, J., Zhang, L., Tang, Y., Zhao, X., Mai, R., Chen, L., Mei, L., et al. (2022) · Viruses · doi:10.3390/v14050854 · Cited by 11
Resch, M. D., Wen, K., Mazboudi, R., Maasz, H. M., Persaud, M., Garvey, K., Gallardo, L., Gottlieb, P., Alimova, A., Khayat, R., et al. (2022) · Vaccines · doi:10.3390/vaccines10121997 · Cited by 10
Roth, N., Gergen, J., Kovacikova, K., Mueller, S. O., Ulrich, L., Schön, J., Halwe, N. J., Fricke, C., Corleis, B., Dorhoi, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11020318 · Cited by 10
Assignment of coronavirus spike protein site-specific glycosylation using GlycReSoftPreprint
Klein, J., & Zaia, J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.31.125302 · Cited by 9
Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cellsPreprint
Miersch, S., Ustav, M., Li, Z., Case, J. B., Ganaie, S. S., Matusali, G., Colavita, F., Lapa, D., Capobianchi, M. R., Novelli, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.05.137349 · Cited by 10
Liu, R., Americo, J. L., Cotter, C. A., Earl, P. L., Noam Erez, A., Peng, C., & Moss, B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.30.424878 · Cited by 10
Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccinePreprint
Reed, C. C., Schultheis, K., Andrade, V. M., Kalia, R., Tur, J., Schouest, B., Elwood, D., Walters, J. N., Maricic, I., Doan, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.11.443592 · Cited by 10
Hoffmann, M. A. G., Yang, Z., Huey‐Tubman, K. E., Cohen, A. A., Gnanapragasam, P. N. P., Nakatomi, L. M., Storm, K. N., Moon, W. J., Lin, P. J. C., & Björkman, P. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.26.521940 · Cited by 10
New star-shaped ligands generated by evolutionary fitting the Omicron spike inner-cavityPreprint
Coll, J. M. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-v8gqj · Cited by 10
Mittal, N., Kumar, S., Rajmani, R. S., Singh, R., Lemoine, C., Jakob, V., Sowrabha, B. J., Jagannath, N., Bhat, M., Chakraborty, D., et al. (2023) · npj Vaccines · doi:10.1038/s41541-023-00755-2 · Cited by 9
Zan, F., Zhou, Y., Chen, T., Chen, Y., Mu, Z., Qian, Z., & Ou, X. (2024) · Viruses · doi:10.3390/v16020223 · Cited by 9
Huang, Q.-L., Lang, Q., Li, Y., Wang, F., Han, X., Luo, L., Duan, X., Cao, X., Wang, Y., Bai, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63084-z · Cited by 10
FN3-based monobodies selective for the receptor binding domain of the SARS-CoV-2 spike protein
Miller, C. J., McGinnis, J. E., Martinez, M. J., Wang, G., Zhou, J., Simmons, E., Amet, T., Abdeen, S. J., Huysse, J. W. V., Bowsher, R. R., et al. (2021) · New Biotechnology · doi:10.1016/j.nbt.2021.01.010 · Cited by 9
Deschambault, Y., Lynch, J., Warner, B. M., Tierney, K. J., Huynh, D., Vendramelli, R., Tailor, N., Frost, K. L., Sajesh, B. V., LeBlanc, K., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00389-22 · Cited by 9
Sulfasalazine colon-specific drug delivery by selenium nanoparticle
Hashemzadeh, A., Asgharzadeh, F., Yaghoubi, A., Nazari, S. E., Hassanian, S. M., Avan, A., Rezaei, M., Soleimanpour, S., & Khazaei, M. (2022) · Journal of Trace Elements and Minerals · doi:10.1016/j.jtemin.2022.100012 · Cited by 9
Infrared Spectroscopy of SARS‐CoV‐2 Viral Protein: from Receptor Binding Domain to Spike Protein
Mancini, T., Macis, S., Mosetti, R., Luchetti, N., Minicozzi, V., Notargiacomo, A., Pea, M., Marcelli, A., Ventura, G. D., Lupi, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202400823 · Cited by 9
Jaishwal, P., Jha, K., & Singh, S. P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134012 · Cited by 10
Nakayama, E. E., & Shioda, T. (2024) · Pathogens · doi:10.3390/pathogens13121109 · Cited by 9
Taşkın‐Tok, T. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.31.005131 · Cited by 9
Boni, C., Cavazzini, D., Bolchi, A., Rossi, M., Vecchi, A. L., Tiezzi, C., Barili, V., Fisicaro, P., Ferrari, C. I., & Ottonello, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730051 · Cited by 9
Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions
Pringle, E. S., Duguay, B. A., Bui-Marinos, M. P., Mulloy, R. P., Landreth, S. L., Desireddy, K. S., Dolliver, S. M., Ying, S., Caddell, T., Tooley, T. H., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010832 · Cited by 10
Yesudhas, D., Srivastava, A., Sekijima, M., & Gromiha, M. M. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26088 · Cited by 9
Routhu, N. K., Gangadhara, S., Cheedarla, N., Shiferaw, A., Rahman, S. A., Sahoo, A., Shi, P., Menachery, V. D., Floyd, K. A., Fischinger, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.27.175166 · Cited by 9
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ SubjectsPreprint
Jennewein, M. F., MacCamy, A. J., Akins, N. R., Feng, J., Homad, L. J., Hurlburt, N. K., Seydoux, E., Wan, Y.-H., Stuart, A. B., Edara, V. V., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.23.436684 · Cited by 9
Self-citationSARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus ImmunogenicityPreprint
Joyce, M. G., Chen, W., Sankhala, R. S., Hajduczki, A., Thomas, P. V., Choe, M., Martinez, E. J., Chang, W. C., Peterson, C. E., Morrison, E. B., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3854502 · Cited by 9
Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman PrimatesPreprint
Corbett, K. S., Gagné, M., Wagner, D. A., Connell, S. O., Narpala, S., Flebbe, D. R., Andrew, S. F., Davis, R. L., Flynn, B. J., Johnston, T. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.11.456015 · Cited by 9
Self-citationDevelopment of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domainsPreprint
Stewart-Jones, G. B. E., Elbashir, S. M., Wu, K., Lee, D. W., Renzi, I., Ying, B., Koch, M., Sein, C. E., Choi, A., Whitener, B. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.07.511319 · Cited by 9
Gagné, M., Flynn, B. J., Andrew, S. F., Flebbe, D. R., Mychalowych, A., Lamb, E., Davis-Gardner, M. E., Burnett, M. R., Serebryannyy, L., Lin, B. C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.06.565765 · Cited by 9
Self-citationGebre, M. S., Rauch, S., Roth, N., Yu, J., Chandrashekar, A., Mercado, N. B., He, X., Liu, J., McMahan, K., Martinot, A., et al. (2021) · doi:10.1101/2021.08.13.456316 · Cited by 8
Puarattana-aroonkorn, S., Tharakaraman, K., Suriyawipada, D., Ruchirawat, M., Fuangthong, M., Sasisekharan, R., & Artpradit, C. (2024) · Vaccines · doi:10.3390/vaccines12060561 · Cited by 8
Yuan, H., Wang, J., Ma, Y., Li, Z., Gao, X., Habib, G., Liu, B., Chen, J., He, J., Zhou, P., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv7296 · Cited by 8
Broad-spectrum coronavirus vaccines: integrated strategies to combat viral diversity
He, Q., Zhang, Y., Fu, Z., Ma, X., & Liang, Z. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2538561 · Cited by 8
Zhang, Y., Li, J., Wang, Z., Kuang, Y., Li, S., & Wang, X. (2025) · Animal Diseases · doi:10.1186/s44149-025-00186-7 · Cited by 9
Jacob, J. J., Fletcher, G. J., Monisha Priya, T., Veeraraghavan, B., & Mutreja, A. (2021) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2021.08.001 · Cited by 8
Ferrari, D., Ambrosi, A., Resta, C. D., Tomaiuolo, R., Locatelli, M., & Banfi, G. (2022) · Journal of Immunological Methods · doi:10.1016/j.jim.2022.113293 · Cited by 8
Zhang, S., Jia, W., Zeng, J., Li, M., Wang, Z., Zhou, H., Zhang, L., & Wang, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.988298 · Cited by 8
Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines
Maison, D. P., Ching, L. L., Cleveland, S. B., Tseng, A. C., Nakano, E. T., Shikuma, C. M., & Nerurkar, V. R. (2022) · Communications Biology · doi:10.1038/s42003-022-04030-3 · Cited by 9
Poumbourios, P., Langer, C., Boo, I., Zakir, T., Akerman, A., Milogiannakis, V., Aggarwal, A., Johnstone, B. A., Ha, J., Coulibaly, F., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1010981 · Cited by 8
Boix‐Besora, A., Gòdia, F., & Cervera, L. (2023) · Vaccines · doi:10.3390/vaccines11111641 · Cited by 9
Swart, M., Kuipers, H., Milder, F. J., Jongeneelen, M. A. C., Ritschel, T., Tolboom, J. T. B. M., Muchene, L. K., van der Lubbe, J. E. M., Gil, A. I., Veldman, D., et al. (2023) · npj Vaccines · doi:10.1038/s41541-023-00772-1 · Cited by 8
Sives, S., Keep, S., Bickerton, E., & Vervelde, L. (2023) · Viruses · doi:10.3390/v15112279 · Cited by 8
Protein data bank: From two epidemics to the global pandemic to mRNA vaccines and Paxlovid
Burley, S. K. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102954 · Cited by 9
Ishay, Y., Kessler, A., Schwarts, A., & Ilan, Y. (2020) · Hepatology Communications · doi:10.1002/hep4.1600 · Cited by 8
Zhang, C., Zhou, C., Shi, L., & Liu, G. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1787064 · Cited by 8
Vaccine development and technology for SARS‐CoV‐2: Current insight
Cattel, L., Giordano, S., Traina, S., Lupia, T., Corcione, S., Angelone, L., Valle, G. L., Rosa, F. G. D., & Cattel, F. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27425 · Cited by 7
Mediu, R., Rama, A., & Puca, E. (2022) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.16310 · Cited by 8
Leav, B. A., Straus, W. L., White, P., Leav, A., Gaines, T., Maggiacomo, G., Kim, D., Smith, E. R., Gurwith, M., & Chen, R. T. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.06.005 · Cited by 9
Scaria, P. V., Rowe, C. G., Chen, B. B., Dickey, T. H., Renn, J. P., Lambert, L., Barnafo, E. K., Rausch, K. M., Tolia, N. H., & Duffy, P. E. (2022) · iScience · doi:10.1016/j.isci.2022.104739 · Cited by 9
Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring
Brady, T. M., Zhang, T., Tuffy, K. M., Haskins, N., Du, Q., Lin, J., Kaplan, G., Novick, S. J., Roe, T. L., Ren, K., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01034-22 · Cited by 7
Jiang, C., Jiang, K., Li, X., Zhang, N., Zhu, W., Meng, L., Zhang, Y., & Lu, S. (2022) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2022.10.003 · Cited by 7
Jang, Y., Cho, H., Chun, J., Park, K., Nowakowska, A., Kim, J., Lee, H., Lee, C., Han, Y., Lee, H.-J., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2022.12.067 · Cited by 8
Metadata
- Authors
- Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., Kong, W.-P., Andres, E. L., Kettenbach, A. N., Denison, M. R., Chappell, J. D., Graham, B. S., Ward, A. B., & McLellan, J. S.
- Affiliations
- Scripps Research Institute (US)
- Dartmouth College (US)
- National Institute of Allergy and Infectious Diseases (US)
- Vanderbilt University Medical Center (US)
- Vanderbilt University (US)
- Corresponding author
- Pallesen, Jesper
- Wang, Nianshuang
- Corbett, Kizzmekia S.
- Ward, Andrew B.
- McLellan, Jason S.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-08-14
- Volume
- 114
- Issue
- 35
- Pages
- E7348-E7357
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5584442
- OpenAlex
- W2750464792
- Cited by
- 1,073
- References
- 89
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 98 · 2023: 127 · 2022: 174 · 2021: 275 · 2020: 220 · 2019: 31 · 2018: 17 · 2017: 6
- FWCI
- 57.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI127521)
- HHS | NIH | National Institute of General Medical Sciences (P20GM113132)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (AI005125)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- MERS-CoV, spike protein, structure-based vaccine design, neutralizing antibodies, receptor binding domain, receptor recognition, membrane fusion mechanism, coronavirus vaccines
- MeSH terms
- Animals, Antibodies, Viral, Coronaviridae, Humans, Immunoglobulin G, Mice, Inbred BALB C, Protein Binding, Protein Conformation, Receptors, Virus, Structure-Activity Relationship, Vaccination, Viral Vaccines, Coronavirus Infections, Crystallography, X-Ray, Immunity, Humoral, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus, Middle East Respiratory Syndrome Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
